Amedeo Smart

Free Medical Literature Service


 

Amedeo

Prostate Cancer

  Free Subscription

Articles published in
Int J Oncol
    September 2025
  1. LONG Z, Chang Y, Zhu K, Chen Z, et al
    Cuproptosis in prostate cancer: Molecular mechanisms, prognostic biomarkers and therapeutic frontiers of cuproptosis?related genes (Review).
    Int J Oncol. 2025;67:77.
    >> Share

    March 2025
  2. MASUD N, Aldahish A, Iczkowski KA, Kale A, et al
    [Retracted] Zinc finger protein?like 1 is a novel neuroendocrine biomarker for prostate cancer.
    Int J Oncol. 2025;66:16.
    >> Share

    February 2025
  3. GRAVINA GL, Marampon F, Giusti I, Carosa E, et al
    [Retracted] Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models.
    Int J Oncol. 2025;66:11.
    >> Share

    November 2024
  4. IIDA K, Zheng R, Shen R, Nanus DM, et al
    [Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.
    Int J Oncol. 2024;65:106.
    >> Share

  5. XU Y, Zhang G, Liu Y, Liu Y, et al
    Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review).
    Int J Oncol. 2024;65:104.
    >> Share

    September 2024
  6. ZHENG XM, Zhang P, Liu MH, Chen P, et al
    [Retracted] MicroRNA?30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3.
    Int J Oncol. 2024;65:82.
    >> Share

    February 2024
  7. NAEEM AA, Abdulsamad SA, Zeng H, He G, et al
    FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells.
    Int J Oncol. 2024;64:18.
    >> Share

  8. ZHONG K, Luo W, Li N, Tan X, et al
    CDK12 regulates angiogenesis of advanced prostate cancer by IGFBP3.
    Int J Oncol. 2024;64:20.
    >> Share

    January 2024
  9. SUN X, Xin S, Zhang Y, Jin L, et al
    [Corrigendum] Long non?coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
    Int J Oncol. 2024;64:5.
    >> Share

    November 2023
  10. FENG K, Liu C, Wang W, Kong P, et al
    Emerging proteins involved in castration?resistant prostate cancer via the AR?dependent and AR?independent pathways (Review).
    Int J Oncol. 2023;63:127.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016